反应详情

By a method similar to that in Example 34, and using, instead of N-{[3-(aminomethyl)phenyl]methyl}-6-cyano-4-oxo-3,4-dihydroquinazoline-2-carboxamide hydrochloride, N-{[3-(aminomethyl)phenyl]methyl}-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide hydrochloride obtained in Reference Example 50 and using, instead of 1H-1,2,4-triazol-3-ylacetic acid, 1-(triphenylmethyl)-1H-1,2,4-triazole-3-carboxylic acid obtained in Reference Example 35, 5-methyl-4-oxo-N-({3-[({[1-(triphenylmethyl)-1H-1,2,4-triazol-3-yl]carbonyl}amino)methyl]phenyl}methyl)-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide was obtained as a white powder (597 mg, 90%).

1. customobtained in Reference Example 50
2. customobtained in Reference Example 35